| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051248910 |
| P356 | DOI | 10.1007/S00228-011-1189-Y |
| P698 | PubMed publication ID | 22258279 |
| P2093 | author name string | Karen Rowland Yeo | |
| David R Plowchalk | |||
| P2860 | cites work | Origins of individual variability in P4501A induction | Q23919659 |
| Expression of CYP1A1 and CYP1A2 genes in human liver | Q28258481 | ||
| The Simcyp population-based ADME simulator | Q28308225 | ||
| Nonparametric expectation maximisation (NPEM) population pharmacokinetic analysis of caffeine disposition from sparse data in adult caucasians: systemic caffeine clearance as a biomarker for cytochrome P450 1A2 activity | Q30886181 | ||
| Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability | Q31044030 | ||
| Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. | Q31096663 | ||
| A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance | Q33532744 | ||
| The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement | Q34181487 | ||
| Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients | Q34288360 | ||
| Effects of tobacco smoking and oral contraceptive use on theophylline disposition | Q34513078 | ||
| Effect of smoking on theophylline disposition | Q34534103 | ||
| The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes | Q35886027 | ||
| Assessment of CYP1A2 activity in clinical practice: why, how, and when? | Q36243462 | ||
| Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance | Q36750350 | ||
| Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms | Q37157901 | ||
| A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn | Q37404434 | ||
| Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. | Q42284296 | ||
| Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis | Q43812136 | ||
| Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables | Q43986056 | ||
| Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine | Q44364145 | ||
| Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma | Q44431086 | ||
| Sex, race, and smoking impact olanzapine exposure. | Q46407545 | ||
| Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients | Q46619086 | ||
| Changes in liver volume from birth to adulthood: a meta-analysis. | Q51959232 | ||
| Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. | Q53422368 | ||
| The absolute bioavailability of caffeine in man | Q57487380 | ||
| Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility | Q57550190 | ||
| Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes | Q58003116 | ||
| Seizures following smoking cessation in a clozapine responder | Q72483494 | ||
| Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism | Q72855479 | ||
| Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients | Q73296823 | ||
| In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity | Q78201960 | ||
| The effect of variable cigarette consumption on the interaction with clozapine and olanzapine | Q79335078 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 951-960 | |
| P577 | publication date | 2012-01-19 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2 | |
| P478 | volume | 68 |
| Q36433323 | A multi-factorial analysis of response to warfarin in a UK prospective cohort |
| Q41768726 | Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development |
| Q58710398 | Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events |
| Q38645189 | Computational oncology--mathematical modelling of drug regimens for precision medicine |
| Q55000530 | Decreased expression of hepatic cytochrome P450 1A2 (CYP1A2) in a chronic intermittent hypoxia mouse model. |
| Q36910606 | Dose selection based on physiologically based pharmacokinetic (PBPK) approaches |
| Q34445462 | Effect of smoking on the pharmacokinetics of inhaled loxapine |
| Q47657663 | Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis |
| Q35111188 | Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine |
| Q28066513 | PBPK modeling and simulation in drug research and development |
| Q64122673 | PharmGKB summary: clozapine pathway, pharmacokinetics |
| Q92531214 | Physiologically-Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and Samidorphan |
| Q91578791 | Physiologically-Based Pharmacokinetic Modeling for the Prediction of CYP2D6-Mediated Gene-Drug-Drug Interactions |
| Q88733301 | Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease |
| Q38760559 | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients |
Search more.